Divis Laboratories Ltd | DIVI - Selling And Administration Expenses


Divis Laboratories Ltd reported INR3.4B in Selling and Administration Expenses for its fiscal quarter ending in June of 2025.





Selling And Administration Expenses Change Date
Alaunos Therapeutics USD 585K 84K Sep/2025
Aurobindo Pharma INR 12.77B 485.3M Sep/2025
Avita Medical AUD 19.03M 1.95M Dec/2025
Dianthus Therapeutics USD 6.57M 1.62M Dec/2025
Divis Laboratories Ltd INR 3.4B 10M Jun/2025
Ionis Pharmaceuticals USD 130M 43.43M Dec/2025
IQVIA Holdings USD 468M 46M Dec/2025
Lupin INR 11.06B 225.6M Sep/2025
Moderna USD 308M 40M Dec/2025
Organon & Co USD 399M 54M Sep/2025
Revvity USD 251.73M 9.82M Dec/2025
Tectonic Therapeutic USD 3.44M 1.52M Dec/2025
Tilray USD 24.85M 1.7M Sep/2025
Viatris USD 1.03B 144.1M Dec/2025
Xeris Pharmaceuticals USD 42.64M 3.82M Dec/2025